Variant mannose-binding lectin 2 genotype is a risk factor for reactive systemic amyloidosis in rheumatoid arthritis

Journal of Internal Medicine

Volumn 262, Issue 4, 2007, Pages 466-469

  Maury, C P J ^a   Aittoniemi, J ^b   Tiitinen, S ^c   Laiho, K ^c   Kaarela, K ^c   Hurme, M ^b,c  

^a UNIVERSITY OF HELSINKI   (Finland)

^b PIRKANMAA HOSPITAL DISTRICT   (Finland)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

Amyloidosis; Mannose binding lectin; MBL2; Polymorphism; Reactive amyloidosis; Rheumatoid arthritis; Risk factor

Indexed keywords

MANNOSE BINDING LECTIN 2;

ADULT; AGED; AMYLOIDOSIS; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE STRUCTURE; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; RHEUMATOID ARTHRITIS; RISK FACTOR;

ADULT; AGED; AMYLOIDOSIS; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LIVER DISEASES; MALE; MANNOSE-BINDING LECTIN; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 34548648494     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2007.01838.x     Document Type: Article

References (24)

1. Dobson CM. Principles of protein folding, misfolding and aggregation. Semin Cell Dev Biol 2004 15 : 3 16.
2. Bukau B, Weissman J, Horwich A. Molecular chaperones and protein quality control. Cell 2006 125 : 443 51.
3. Pepys MB. Amyloidosis. Annu Rev Med 2006 57 : 223 41.
4. Falck HM, Maury CPJ, Teppo AM, Wegelius O. Correlation of persistently high serum amyloid A and C-reactive protein concentrations with rapid progression of secondary amyloidosis. Br Med J 1983 286 : 1391 3.
5. Gillmore JD, Lovat LB, Persey MP, Pepys MB, Hawkins PN. Amyloid load and clinical outcome in relation to circulating concentration of serum amyloid A protein. Lancet 2001 358 : 24 9.
6. Ogden CA, deCathelineau A, Hoffmann PR et al. C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J Exp Med 2001 194 : 781 95.
7. Tsutsumi A, Takahashi R, Sumida T. Mannose binding lectin: genetics and autoimmune disease. Autoimmun Rev 2005 4 : 364 72.
8. Garred P, Larsen F, Seyfarth J, Fuijta R, Madsen HO. Mannose-binding lectin and its genetic variants. Genes Immun 2006 7 : 85 94.
9. Worthley DL, Bardy PG, Mullighan CG. Mannose-binding lectin: biology and clinical implications. Intern Med J 2005 35 : 548 55.
10. Madsen HO, Garred P, Kurtzhals JA et al. A new frequent allele is the missing link in the structural polymorphism of the human mannan-binding protein. Immunogenetics 1994 40 : 37 44.
11. Madsen HO, Garred P, Thiel S et al. Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. J Immunol 1995 155 : 3013 20.
12. Fuks A, Zucker-Franklin D. Impaired Kupffer cell function precedes development of secondary amyloidosis. J Exp Med 1985 161 : 1013 28.
13. Kuroiwa M, Aoki K, Izumiyama N. Histological study of experimental murine AA amyloidosis. J Electron Microsc 2003 52 : 407 13.
14. Ham D, Skoryna SC. Generation of amyloid A protein by the cell lines from amyloid-susceptible and -resistant mice. Scand J Immunol 2004 59 : 117 22.
15. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988 31 : 315 24.
16. Maury CPJ, Tiitinen S, Laiho K, Kaarela K, Liljeström M. Raised circulating interleukin-18 levels in reactive AA-amyloidosis. Amyloid 2002 9 : 141 4.
17. Maury CPJ, Liljeström M, Laiho K, Tiitinen S, Kaarela K, Hurme M Tumor necrosis factor α, its soluble receptor I, and -308 gene promoter polymorphism in patients with rheumatoid arthritis with or without amyloidosis. Implications for the pathogenesis of nephropathy and anemia of chronic disease in reactive amyloidosis. Arthritis Rheum 2003 48 : 68 76.
18. Maury CPJ, Liljeström M, Laiho K, Tiitinen S, Kaarela K, Hurme M. Anaemia of chronic disease in patients with AA-amyloidosis: relationship to polymorphisms of the interleukin-1 gene complex and circulating cytokine levels. J Intern Med 2004 256 : 145 52.
19. Phipps-Yonas H, Pinard G, Ali-Khan Z. Humoral proinflammatory cytokine and SAA generation profiles and spatio-temporal relationships between SAA and lysosomal cathepsin B and D in murine splenic monocytoid cells during AA amyloidosis. Scand J Immunol 2004 59 : 168 76.
20. Migita K, Yamasaki S, Shibatomi K et al. Impaired degradation of serum amyloid A (SAA) protein by cytokine-stimulated monocytes. Clin Exp Immunol 2001 123 : 408 11.
21. Graudal NA, Madsen HO, Tarp U et al. The association of variant mannose-binding lectin genotypes with radiographic outcome in rheumatoid arthritis. Arthritis Rheum 2000 43 : 515 21.
22. Jacobsen S, Madsen HO, Klarlund M et al. The influence of mannose binding lectin polymorphisms on disease outcome in early polyarthritis.TIRA Group. J Rheumatol 2001 28 : 935 42.
23. Stanworth SJ, Donn RP, Hassall A, Dawes P, Ollier W, Snowden N. Absence of an association between mannose-binding lectin polymorphism and rheumatoid arthritis. Br J Rheumatol 1998 37 : 186 8.
24. Aittoniemi J, Soranummi H, Rovio AT et al. Mannose-binding lectin 2 (MBL2) gene polymorphism in asthma and atopy among adults. Clin Exp Immunol 2005 142 : 120 4.